Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitors
Open Access
- 29 July 2020
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (10)
Abstract
Peripheral sympathetic nervous system tumors are the most common extracranial solid tumors of childhood and include neuroblastoma, ganglioneuroblastoma, and ganglioneuroma. Surgery is the only effective therapy for ganglioneuroma, which may be challenging due to the location of the tumor and involvement of surrounding structures. Thus, there is a need for well-tolerated presurgical therapies that could reduce the size and extent of ganglioneuroma and therefore limit surgical morbidity. Here, we found that an AKT–mTOR–S6 pathway was active in human ganglioneuroma but not neuroblastoma samples. Zebrafish transgenic for constitutively activated myr-Akt2 in the sympathetic nervous system were found to develop ganglioneuroma without progression to neuroblastoma. Inhibition of the downstream AKT target, mTOR, in zebrafish with ganglioneuroma effectively reduced the tumor burden. Our results implicate activated AKT as a tumorigenic driver in ganglioneuroma. We propose a clinical trial of mTOR inhibitors as a means to shrink large ganglioneuromas before resection in order to reduce surgical morbidity.Keywords
Funding Information
- National Institutes of Health (5 P30 CA06516)
- National Institutes of Health (R01-CA180692)
- Pediatric Cancer Research Foundation
- Rally Foundation for Childhood Cancer Research
- Open Hands Overflowing Hearts
- Rally Foundation for Childhood Cancer Research
- CureSearch for Children’s Cancer
- American Society of Clinical Oncology
- Damon Runyon-Sohn (DRSG-24-18)
- Alex’s Lemonade Stand Foundation for Childhood Cancer
This publication has 63 references indexed in Scilit:
- Deriving Cell Lines from Zebrafish Embryos and TumorsZebrafish, 2013
- Def defines a conserved nucleolar pathway that leads p53 to proteasome-independent degradationCell Research, 2013
- Activated ALK Collaborates with MYCN in Neuroblastoma PathogenesisCancer Cell, 2012
- Deletion of Pten in the mouse enteric nervous system induces ganglioneuromatosis and mimics intestinal pseudoobstructionJournal of Clinical Investigation, 2009
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- TopHat: discovering splice junctions with RNA-SeqBioinformatics, 2009
- Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic ZebrafishOncogene, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Germline Mutations of the Paired–Like Homeobox 2B (PHOX2B) Gene in NeuroblastomaThe American Journal of Human Genetics, 2004